Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mjafi.2014.01.001 http://scihub22266oqcxt.onion/10.1016/j.mjafi.2014.01.001 C4213889!4213889!25378777     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+J+Armed+Forces+India 2014 ; 70 (3): 243-6 Nephropedia Template TP {{tp|p=25378777|t=2014. Drug-eluting balloon: Initial experience in patients with in-stent restenosis (ISR) |pdf=|usr=}}{{25378777}} gab.com Text Drug-eluting balloon: Initial experience in patients with in-stent restenosis (ISR) JO: Med J Armed Forces India http://www.kidney.de/pget.php?&tw=1&pmid=25378777 #FOAvip Background: In-stent restenosis is the most important limitation of modern coronary angioplasty. Drug-eluting stents solve this problem but at the cost of late stent thrombosis and longer duration of dual-antiplatelet therapy. Drug-eluting balloon (DEB) technology is now available and offers an attractive option for treatment of restenosis. Methods: A cohort of 20 patients with in-stent restenosis after stenting were treated with a drug-eluting balloon and were followed up clinically and angiographically for 6 months. Results and conclusion: Procedural success was achieved in all patients. 6 month clinical follow-up was available for all and 6 month angiographic follow up for 17 patients. On 6 month follow-up, 5 of the 20 patients had recurrence of angina and 4 patients had angiographic restenosis (2 focal, 2 diffuse). The mean Canadian Cardiovascular Society angina score improved significantly from 3.1 to 1.1. DEB offers a novel method of treatment for patients with in-stent restenosis with a good safety and efficacy profile. Twit Text FOAVip Drug-eluting balloon: Initial experience in patients with in-stent restenosis (ISR) ????Med J Armed Forces India http://www.kidney.de/pget.php?&tw=1&pmid=25378777 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25378777 #FOAvip English Wikipedia <ref>{{Cite pmid|25378777}}</ref> Drug-eluting balloon: Initial experience in patients with in-stent restenosis (ISR) #MMPMID25378777 Swamy A; Kumar A; Keshavamurthy G; Chadha D Med J Armed Forces India 2014[Jul]; 70 (3): 243-6 PMID25378777show ga Background: In-stent restenosis is the most important limitation of modern coronary angioplasty. Drug-eluting stents solve this problem but at the cost of late stent thrombosis and longer duration of dual-antiplatelet therapy. Drug-eluting balloon (DEB) technology is now available and offers an attractive option for treatment of restenosis. Methods: A cohort of 20 patients with in-stent restenosis after stenting were treated with a drug-eluting balloon and were followed up clinically and angiographically for 6 months. Results and conclusion: Procedural success was achieved in all patients. 6 month clinical follow-up was available for all and 6 month angiographic follow up for 17 patients. On 6 month follow-up, 5 of the 20 patients had recurrence of angina and 4 patients had angiographic restenosis (2 focal, 2 diffuse). The mean Canadian Cardiovascular Society angina score improved significantly from 3.1 to 1.1. DEB offers a novel method of treatment for patients with in-stent restenosis with a good safety and efficacy profile. äDrug-eluting balloon: Initial experience in patients with in-stent res(epmc).pdf DeepDyve Pubget Overpricing